Viruses require host cell metabolites to productively infect, and the mechanisms by which 25 viruses usurp these molecules is diverse. One group of cellular metabolites important in virus 26 infection is the polyamines, small positively-charged molecules involved in cell cycle, translation, 27 and nucleic acid synthesis, among other cellular functions. Polyamines also support replication 28 of diverse viruses, and they are important for processes such as transcription, translation, and 29 viral protein enzymatic activity. Rift Valley fever virus (RVFV) is a negative-sense RNA virus that 30 requires polyamines to produce infectious particles. In polyamine depleted conditions, 31 noninfectious particles are produced that interfere with virus replication and stimulate immune 32 signaling. Here, we find that RVFV relies on virion-associated polyamines to maintain infectivity. 33
Introduction

47
Rift Valley fever virus (RVFV) is a significant human and ruminant pathogen, associated with 48 hemorrhagic fever and spontaneous abortion. While the virus is currently geographically 49 restricted to Africa and the Middle East, the potential for spread globally is significant. Further, 50 RVFV is a mosquito-borne virus, and chikungunya 1 and Zika 2 virus demonstrate that these 51 viruses can spread globally and explosively. Both Culex and Aedes species of mosquitoes 52 transmit RVFV 3-5 , though the breadth of vectors susceptible to RVFV is not fully understood. 53
Fortunately, several vaccine candidates [6] [7] [8] show promise in reducing transmission, including in 54 animals. However, adverse events associated with these vaccines have limited their use, and 55
Polyamines not synthesized in eukaryotes also support viral replication. The biogenic 134 polyamines are found in all eukaryotic cells examined. Given the relatively simple structure of 135 polyamines, consisting of carbon chains with primary and secondary amines, we hypothesized 136 that additional non-biogenic molecules with similar structures may also enhance virus 137 replication. To test this, we treated Huh7 cells with 1 mM DFMO, infected with RVFV, and 138 supplemented cells with an array of polyamines at 10 µM at the time of infection (a selection of 139 structures shown in Figure 1C . All polyamines except putrescine, spermidine, and spermine are 140 not synthesized in eukaryotic cells and are non-biogenic). When we measured viral titers at 48 141 hpi, we observed that biogenic polyamines fully rescued viral titers; however, we also observed 142 that the polyamines cadaverine (1,4-diaminopentane, one carbon longer than putrescine) and 143 norspermidine (one fewer carbon than spermidine), two polyamines not synthesized by 144 eukaryotic cells, rescued viral titers to nearly equivalent levels as the biogenic polyamines 145 ( Figure 1D ). Interestingly, we observed that no other non-biogenic polyamines enhanced titers 146 beyond DFMO treatment levels, despite their structural similarity. Of particular interest, 147 butylamine, which is similar to putrescine but lacks an amino group, failed to enhance 148 replication. Additionally, elongating the putrescine carbon chain to six (diaminohexane) or seven 149 (diaminoheptane) carbons or shortening the chain to three carbons also eliminated 150 enhancement of virus replication. Again, we tested this set of polyamines with LACV and 151 observed that cadaverine and norspermidine again enhanced viral titers, while all other 152 compounds did not, suggesting conservation in polyamine usage between these two 153 bunyaviruses ( Figure 1E ). 154 155 Finally, we used an enterovirus model of infection, Coxsackievirus B3 (CVB3) to test its 156 sensitivity to distinct polyamines. As with RVFV and LACV, we treated cells with DFMO and biogenic polyamines also maintain specific infectivity of RVFV, we measured the ratio of 168 genomes to infectious virus, as measured by plaque assay. We treated Huh7 cells with 1 mM 169 DFMO prior to infection at MOI 0.1. At the time of infection, we added 100 µM putrescine, 170 spermidine, or spermine. After 48 h, supernatant was collected for titration and RNA purification. 171 RNA was reverse transcribed and analyzed for RVFV genomes using virus-specific primers. We 172 then calculated the genome-to-PFU ratio as a measure of specific infectivity. Similar to our 173 previous work, polyamine depletion increased the ratio of genomes to PFU (Figure 2A) , 174 suggesting reduced specific infectivity. However, addition of putrescine or spermine returned 175 this ratio to untreated levels and modestly increased specific infectivity (fewer genomes per 176 PFU) with spermidine treatment. We performed a similar analysis for LACV and observed the 177 same phenotype: DFMO treatment increases the genome-to-PFU ratios, while the biogenic 178 polyamines reduce to untreated levels ( Figure 2B ). 179
180
Measuring genome-to-PFU is a surrogate for measuring the number of viral particles compared 181 to the number of these particles that are infectious. To more accurately measure particle-to-PFU 182 ratio, we used a method similar to Wichgers Schreur and colleagues to stain viral particles 183 fluorescently 35 . We spinoculated virus on coverslips and stained for viral envelope glycoprotein 184 Gc or Gn using specific antibodies and FITC-tagged fluorescent secondary antibody. To 185 establish the assay, we tested both antibodies to ensure specificity and that we weren't 186 observing aberrations due to impurities on the coverslips or nonspecific staining. Using 187 spinoculated virus derived from infected and uninfected cells, we observed dots corresponding 188 to virus in only samples that were infected, no detectable signal was observed on slides 189 spinoculated with samples from uninfected cells ( Figure 2C ). We next applied this method to 190 virus derived from DFMO-treated cells as well as cells supplemented with various polyamines. 191
Again, virus was spinoculated from mock-or virus-infected cell supernatant and stained with 192 anti-Gn and FITC-tagged secondary. As a control, we also stained with a secondary antibody 193 fluorescent in the red channel (TxRed). When we visualized the samples, we observed distinct 194 puncta only in infected samples and not in mock samples ( Figure 2D ). We also observed no 195 staining in the red channel, suggesting that we were again not observing impurities on the 196 coverslips ( Figure 2D , "Red channel"). We counted the number of dots using ImageJ and back-197 calculated the number of particles per mL of infected cell supernatant ( Figure 2E ). We used this 198 number to calculate the particle-to-PFU ratio ( Figure 2F ). Supporting our genome-to-PFU 199 ratios, we observed that untreated cells had a paticle-to-PFU ratio of approximately 20, and the genome-to-PFU ratio, as well as the particle-to-PFU ratio, as measured by our two methods. 202
To expand our rescue experiments, we similarly stained particles derived from infection of 203 DFMO-treated and polyamine-supplemented cells. As with our genome-to-PFU ratio, we 204 observe that addition of any of the biogenic polyamines returns the particle-to-PFU ratio to 205 untreated levels, with a small, though significant, reduction in this ratio, suggesting that 206 polyamines support RVFV infectivity. 207
208
Polyamines are associated with the RVFV virion. We observe a change in specific infectivity 209 (as measured by genome-to-PFU or particle-to-PFU), and we previously characterized that the 210 physical and structural properties of virions produced with or without polyamines are 211 indistinguishable. We next considered that polyamines might be associated with RVFV virions 212 themselves. In fact, polyamines are found in the virions of several DNA viruses and a subset of 213 RNA viruses. To this end, we used a fluorometric assay, which directly measures polyamine 214 content in cells. We generated virus in Huh7 cells left untreated or treated with 1 mM DFMO by 215 infecting at MOI 0.1 for 48 h. After 48 h, we purified virus by sucrose cushion ultracentrifugation, 216 resuspended the viral pellet in PBS, and analyzed polyamine association. As a control, we used 217 mock-infected supernatant and performed all steps in tandem with virus-infected cell 218 supernatant. As expected, our purified mock-infected supernatant had no signal ( Figure 3A ). 219
Similarly, CVB3-infected cell supernatant exhibited no detectable signal above background, as 220 expected 23 . As a positive control 22 , we observed detectable levels of polyamines in purified 221 vaccinia virus (VACV), and this signal returned to background levels when virus was derived 222 from DFMO-treated conditions. When we tested RVFV, we observed signal above background, 223 though not as intense as VACV, and this signal was depleted when virus was derived from 224 DFMO-treated cells. These results suggest that purified RVFV virions are associated with 225 polyamines. 226 227 Importantly, the fluorescent polyamine assay does not distinguish between polyamines in the 228 cell; thus, this assay could not dictate which specific polyamine is associated with virions. In 229 order to identify the polyamine(s), we purified and concentrated RVFV from Huh7 cells 230 (approximately 10 6 PFU total) as above, labeled polyamines via dansylation, and resolved the 231 dansylated polyamines via thin layer chromatography (TLC). When we analyzed mock-infected 232 cell supernatant, we observed no polyamines, as expected ( Figure 3B ). The whole cell lysate 233 (WCL) from cells infected with RVFV contained robust amounts of spermidine and spermine, band corresponding to spermidine, and this band was lost when virus was purified from DFMO-236 treated cells. LACV also showed virion-associated spermidine, while human rhinovirus serotype 237 2 (HRV2, enterovirus distantly related to CVB3) had no detectable polyamines, as expected. 238
These data again detect virion-associated polyamines, which we have identified as spermidine. 239 240 Polyamines interconvert upon replenishment of DFMO-treated cells. We next considered 241 whether we could deplete polyamines from cells, replenish with individual biogenic polyamines 242 and detect these species in the RVFV virion. To this end, we treated Huh7 cells with 1 mM 243 DFMO, infected with RVFV at MOI 0.1, and added 10 µM putrescine, spermidine, or spermine 244 individually at the time of infection. As a control, we added ornithine, the polyamine precursor. 245
As before, we purified and concentrated virions and analyzed polyamine content by thin layer 246 chromatography. As expected, virions purified from DFMO-treated cells exhibited no 247 polyamines; however, polyamine supplementation resulted in detectable virion-associated 248 polyamines ( Figure 4A ). Interestingly, both putrescine and spermine supplementation led to a 249 detectable level of virion-associated spermidine. Given that DFMO blocks the production but not 250 the interconversion of polyamines, we considered that supplemented putrescine and spermine 251 might generate spermidine through the actions of spermidine synthase (SMS) or polyamine 252 oxidase (PAOX) with spermidine/spermine acetyltransferase (SAT1). We measured polyamine 253 levels in DFMO-treated cells that were supplemented with the polyamines and observed that 254 with putrescine, spermidine, or spermine supplementation, spermidine was abundant on our 255 TLC ( Figure 4B ). Thus, the biogenic polyamines rapidly interconvert and specifically spermidine 256 is virion associated in this polyamine milieu. 257 258 While eukaryotic cells can interconvert the biogenic polyamines, no description of their ability to 259 interconvert cadaverine or norspermidine has been reported. Thus, we tested whether 260 supplementation of these polyamines, which rescues viral titers, can support polyamine 261 packaging. To this end, we generated and purified virus from DFMO-treated cells supplemented 262 with 10 µM cadaverine or norspermidine and measure virion-associated polyamines by TLC. 263
Curiously, we detected bands near the retention factor (Rf) of spermidine, though not precisely 264 at spermidine's Rf ( Figure 4C ). Our standards ( Figure 4C , right) suggest that norspermidine is, 265 in fact, associated with RVFV virions. However, the band in the cadaverine lane was faint and 266 migrated slightly higher in the chromatogram. This band could be N(3-aminopropyl)cadaverine, 267
which is a single carbon longer than spermidine, though this molecule has not been described 268 to be synthesized in human cells. We checked whether we could detect this species in cells ( Figure 4D ), and we can in fact a molecule that runs as N(3-aminopropyl)cadaverine would. 270
However, we also observe that norspermidine is not interconverted into other detectable 271 polyamine species. In sum, however, it appears that polyamines within a limit can replace 272 spermidine for RVFV virions. we measured titers at 48 hpi, we observed a full rescue in titers, to a level similar to spermidine. 284
We titrated (R)-3-methylspermidine after DFMO treatment and observed that concentrations 285 around 10 µM were sufficient to fully rescue viral titers ( Figure 5B ), slightly higher than for 286 spermidine ( Figure 1A ). Thus, methylated spermidine functions to support RVFV infection. 287
288
To test if (R)-3-methylspermidine could associate with virions, we purified virions and visualized 289 polyamines by TLC. As expected, we observed that RVFV was associated with spermidine; 290 however, we could detect bands corresponding to (R)-3-methylspermidine as well ( Figure 5D ), 291
suggesting that this polyamine is virion-associated. To confirm that 3-methylspermidine was not 292 interconverted to the biogenic polyamines, we also performed TLC on the treated cells and 293 observed no such interconversion ( Figure 5E ). 294 295 We previously showed that virions derived from DFMO-treated cells show no distinctions in their 296 gross appearance by electron microscopy. To confirm this phenotype as well as to determine 297 whether polyamine rescue with 3-methylspermidine could change virion morphology, we purified 298 virions and examined them by electron microscopy. In untreated conditions, we observed 299 numerous virions of expected size and with visible surface glycoproteins ( Figure 5F ). As 300 previously described, DFMO treatment did not noticeably change virion appearance, and discernible effect on virion appearance. Thus, polyamines do not appear to contribute to virion 303 morphology. 304
305
Polyamines are transmitted to naïve cells upon infection. Given that polyamines, 306 specifically spermidine, are associated with RVFV virions, we considered that virus infection 307 may transmit polyamines to newly-infected cells. We generated virus stock from untreated and 308 DFMO-treated cells ( Figure 6A ) and then used these viruses to infect polyamine-sensitive 309 luciferase reporter cells. These reporter cells consist of 293T cells transfected with an OAZ1 310 dual-luciferase construct. Briefly, OAZ1 transcript is sensitive to cellular polyamine levels: high 311 polyamines result in enhanced stability and translation; low polyamines result in reduced 312 stability and translation. With this construct, we can measure luciferase activity to indirectly 313 measure polyamine levels in cells: polyamine levels directly correlate with firefly luciferase 314 activity, which is normalized to renilla luciferase activity that is polyamine-independent. We 315 treated these reporter cells with DFMO and observed a significant reduction in luciferase 316 activity, corresponding to reduced polyamine levels. To these DFMO-treated reporter cells, we 317 added 10 µM polyamines (equimolar mixture of the biogenic polyamines) and observed 318 enhanced luciferase activity, demonstrating their responsiveness to polyamines. We also added 319 purified RVFV virions (10 3 , 5x10 3 , and 10 4 PFU), for which we observed a dose-dependent 320 increase in signal ( Figure 6B ). When we added virus (10 4 pfu) derived from DFMO-treated cells 321 or when we purified supernatant from mock-infected cells, we did not observe an increase in 322 luciferase activity, indicating that we are not observing a cellular response to infection or 323 aberrantly purifying polyamines from cellular supernatant. In sum, these data suggest that 324 RVFV can transmit polyamines upon infection. 325 326 RVFV particles devoid of polyamines rapidly lose infectivity. Polyamines facilitate infection 327 and polyamine depletion results in the genesis of non-infectious particles. Additionally, we can 328 detect spermidine (and highly similar non-biogenic polyamines) in purified RVFV. We 329 hypothesized that these non-infectious particles may be due to a decline in viral infectivity from 330 a lack of virion-associated polyamines. To test this, we generated virus from untreated and 331 DFMO-treated Huh7 cells and incubated the cell-free supernatant at 37 o C for 24h, taking 332 samples at regular intervals to titer. We observed that virus derived from untreated cells slowly 333 declined in titer ( Figure 7A ), resulting in a modest reduction in titers over 24h. The calculated rapidly lost infectivity, with titers dropping by about 90% within 24h and a half-life of 336 approximately 14.4h. Thus, polyamine-depleted cells generate virus that rapidly loses infectivity. 337 338 We first considered that DFMO itself was destabilizing RVFV virions. Thus, we incubated virus 339 with 1 mM or 500 µM DFMO for 24h at 37 o C. We observed that DFMO itself did not destabilize 340 the virus, as titers were equivalent between untreated and DFMO-treated viruses ( Figure 7B) . 341
Because spermidine is found in association with purified RVFV virions, we next hypothesized 342 that polyamines themselves may stabilize virions. To this end, we incubated virus generated 343 from untreated or DFMO-treated cells with 10 µM spermidine or spermine and incubated at 344 37 o C for 24h. We observed decay of the virus derived from DFMO-treated cells accelerated 345 compared to untreated cells, with no difference regardless of polyamine treatment ( Figure 7C ). 346
These data suggest that polyamines do not stabilize RVFV when added exogenously. Together, 347 these data suggest that polyamines help to maintain infectivity, that this is not due to DFMO 348 itself, and that exogenous polyamines cannot stabilize virions. 349
350
To extend these results to the related bunyavirus LACV, we similarly incubated virus derived 351 from untreated and DFMO-treated conditions and measured infectivity over 24h. As with RVFV, 352
we observed a steep decline in virus titers, though the effect was primarily at 48 hpi ( Figure 7D ). 353
Thus, LACV exhibits similar sensitivity to losing infectivity when the virus is derived from DFMO-354 treated cells. 355 356 Finally, we considered whether we could potentially resurrect infectivity of our viral particles by 357 incubating them with polyamines, specifically spermidine. To this end, we incubated virus from 358 untreated and DFMO conditions with increasing doses of spermidine for 24h at 37 o C. We 359 observed no significant difference in titer from spermidine treatment ( Figure 7E ), suggesting that 360 spermidine supplementation cannot rescue infectivity of the virions once they have lost 361 infectivity. 362 363
Discussion
364
As obligate intracellular pathogens, viruses rely on the host to provide metabolites for 365 replication. The virion itself is composed of molecules derived from the host but directed for 366 assembly and order by the viral genome. The genomic nucleotides, proteins' amino acids, and polyamines in the virions of herpesviruses 21 and poxviruses 22 . However, other viruses do not 370 appear to consistently incorporate polyamines into virions. For example, negligible amounts of 371 polyamines are detected associated with poliovirus capsids, but rhinovirus 14 had a detectable 372 amount, enough to neutralize approximately 16% of the genome 23 . Adenovirus-5, a DNA virus, 373 also appears to incorporate small amounts of polyamines 37 . Thus, the packaging of polyamines 374 and the role(s) of these packaged polyamines is not necessarily evolutionarily conserved. 375
Additionally, the presence of these polyamines had not been examined in bunyaviruses. 376 377 We specifically observe that spermidine is associated with RVFV and LACV virions, despite 378 cellular polyamine pools comprising primarily spermidine and spermine. Other viruses 379 incorporate polyamines without specificity; for example, densoviruses have all three polyamines 380 in purified virus 38 . Interestingly, herpesviruses package spermidine and spermine, with 381 spermidine primarily associated with the envelope or tegument and spermine in the viral 382 capsid 21 . Given that bunyaviruses like RVFV do not have a bona fide capsid, one could 383 speculate that the viral envelope specifically associates with spermidine, given that both viruses 384 have a lipid membrane component. The localization of polyamines in RVFV may further inform 385 the function of these polyamines in the virion. Additionally, the mechanism by which virions 386 incorporate spermidine but exclude the other polyamines is not known for this or other viruses. 387
Whether spermidine incorporation is an active process by the virus or a product of RNA-, 388 protein-, or lipid-spermidine interactions will be an important distinction to make. 389 390 Despite the specific association of spermidine with purified virions, we observe that any of the 391 biogenic polyamines (putrescine, spermidine, and spermine) supports viral infection. 392 Importantly, when treating cells with these polyamines, they interconvert and produce the full 393 complement of cellular polyamines. In fact, we observe this in our system, and those cells 394 replenished with any of the biogenic polyamines support virus infection and spermidine 395 association with virions. Thus, the balance of polyamines is crucial to cellular homeostasis 16 and 396 virus replication. Interestingly, RVFV exhibits some flexibility in polyamine utilization, as we can 397 detect molecules that are a single carbon longer or shorter than spermidine in virions. 398
Interestingly, cells exhibit heterogeneity in their polyamine composition and, thus, if viruses 399
differentially utilize polyamines, the cellular polyamine composition may alter infection and 400 pathogenesis. Regardless, whether distinct polyamines function differently during RVFV 401 infection remains to be fully understood. 402
We previously observed that polyamine depletion led to the accumulation of noninfectious viral 404 particles that interfered with productive virus infection 27 . We were unable to find a physical 405 distinction between infectious and noninfectious virions, however. These studies suggest that a 406 component of the virus that may be maintaining infectivity is spermidine, as viruses lacking 407 polyamines are more labile than viruses propagated in cells with polyamines. However, these 408 results do not preclude that an additional polyamine-modulated factor may contribute to virion 409 stability. In fact, polyamine depletion affects several cellular processes. Regardless, we observe 410 that polyamine depletion generates viral particles lacking polyamines that rapidly lose infectivity. 411
Future work will address the mechanisms behind this lability. (3-methylspermidine) was derived as described previously 39 Purified RNA was subsequently used for cDNA synthesis using High Capacity cDNA Reverse 496
Transcription Kits (Thermo-Fischer), according to the manufacturer's protocol, with 10-100 ng of 497 RNA and random hexamer primers. 498 499 Viral genome quantification. Following cDNA synthesis, qRT-PCR was performed using the 500 QuantStudio3 (Applied Biosystems by Thermo-Fischer) and SYBR green mastermix 501 (DotScientific). Samples were held at 95 C for 2 mins prior to 40 cycles of 95 C for 1s and 502 60 C for 30s. Primers were verified for linearity using eight-fold serial diluted cDNA and 503 checked for specificity via melt curve analysis following by agarose gel electrophoresis. All 504 samples were used to normalize to total RNA using the Δ C T method. Primers against the RVFV small genome were 5'-CAG-CAG-CAA-CTC-GTG-ATA-GA-3' (forward) and 5'-CCC-GGA-GGA-506 TGA-TGA-TGA-AA-3'. Primers for LACV small genome were 5'-GGC-AGG-TGG-AGG-TTA-507 TCA-AT-3' (forward) and 5'-AAG-GAC-CCA-TCT-GGC-TAA-ATA-C-3' (reverse). GAPDH 508 primers were 5'-GAT-TCC-ACC-CAT-GGC-AAA-TTC-3' (forward) and 5'-CTG-GAA-GAT-GGT-509 GAT-GGG-ATT-3' (reverse). 510 511 Genome-to-PFU ratio calculations. The number of viral genomes quantified as described 512 above were divided by the viral titer, as determined by plaque assay, to measure the genome-513 to-PFU ratio. Values obtained were normalized to untreated conditions to obtain the relative 514 genome-to-PFU ratio. We are gracious to Thomas Gallagher for critical discussion and helpful insights concerning this 546 project. We thank Susan Uprichard for Huh7 cells and Makio Iwashima for THP-1 cells, as well 547 as helpful discussion. We also thank Shinji Makino and Kaori Terasaki for generously providing 548 the MP-12 strain of RVFV. We appreciate immunofluorescent imaging help and input from the 
